Eun-Mi Yu MD

PubMed

• Harnessing genomic profiling for improved urothelial cancer outcomes.
  Eun-Mi Yu, Laura Linville, Min Woo Hwang, Youngjoo Kim, Kevin Li
  Expert Review of Anticancer Therapy. 2025-10-20
• The rapidly changing treatment landscape of first-line advanced urothelial cancer (aUC) or metastatic urothelial cancer (mUC).
  Minira Aslanova, Eun-Mi Yu, Jeanny B Aragon-Ching
  Exploration of Targeted Anti-Tumor Therapy. 2024-01-01
• 1 citations
  The Rapidly Evolving Treatment Landscape of Metastatic Hormone-Sensitive Prostate Cancer.
  Eun-Mi Yu, Ishan Patel, Min Woo Hwang, Faran Polani, Jeanny B Aragon-Ching
  Clinical Medicine Insights. Oncology. 2024-01-01

Journal Articles

• Complete response to EPOCH in a patient with HIV and extracavitary primary effusion lymphoma involving the colon: a case report and review of literature  
  El-Ayass W, Yu EM, Karcher DS, Aragon-Ching JB, Clin Lymphoma Myeloma Leuk, 4/1/2012
• Angiogenesis inhibitors in prostate cancer therapy  
  Yu EM, Jain M, Aragon-Ching JB, Discov Med, 12/1/2010
• The use of 5-alpha reductase inhibitors for the prevention of prostate cancer  
  Yu EM, El-Ayass W, Aragon-Ching JB, Cancer Biol Ther, 7/1/2010

Books/Book Chapters

• Leiomyosarcoma: Risk Factors, Diagnosis and Treatment Options 
  Chapter: Leiomyosarcomas of the Genitourinary Tract 
  Page 75 - 90Yu EM, Kittai A, Aragon-Ching JBNova Science Publishers, New YorkEdition 1st,2014